Company profile

Kivo Health

Chronic Disease Management & Digital Therapeutics

Company profile

About Kivo Health

Kivo Health is a digital therapeutics company that delivers AI-powered virtual pulmonary rehabilitation and care programs specifically designed for people managing chronic obstructive pulmonary disease (COPD). The company's mission is to empower one billion people with chronic lung disease to breathe easier and live better. Kivo's evidence-based program is delivered entirely from patients' homes, eliminating access barriers associated with traditional in-person pulmonary rehabilitation. The program includes a comprehensive 9-week structured intervention featuring one-on-one assessments with licensed respiratory therapists, personalized small group video sessions twice weekly, targeted aerobic and anaerobic exercises, breathing techniques, medication management education, and ongoing maintenance support. Patients receive a complete kit with tablet, oxygen monitor, and exercise equipment, with cellular connectivity provided for those without WiFi. The program demonstrates strong clinical outcomes with 24% improvement in symptoms, 34% improvement in physical activity, 25% improvement in mood, and an industry-leading 83% completion rate. For healthcare partners, Kivo delivers a 3.1x return on investment, primarily through reduced inpatient and skilled nursing facility costs, with projected savings of $8,245 per member per year and nearly $10 million in annual savings per 100,000 Medicare Advantage members. The company is backed by Y Combinator and serves individuals, physicians, health systems, population health organizations, and health plans including Medicare, Medicaid, United Healthcare, Humana, Blue Cross, Aetna, Priority Health, and Clover Health.

Company description Kivo Health official website

Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Kivo Health?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • chronic lung disease
  • Chronic Obstructive Pulmonary Disease (COPD)

Who it serves

  • Health Plans
  • Health Systems
  • Medicaid Plans
  • Medicare Advantage Plans
  • Physicians
  • Population Health Organizations

Deployment & integration

Cloud Saas deployment with recorded integration context.

Geographic context

MarketsCalifornia · United States
Company sourceOfficial website

Company milestones

Platform expansion

April 2026: Partnership with Optum Arcadia for AI-powered virtual lung rehab in California. December 2025: Partnership with Priority Health. July 2025: Collaboration with Stanford Health Care. June 2025: Stanford Health Care collaboration for value-based care. May 2025: Published positive results in peer-reviewed study. February 2023: Company launch backed by Y Combinator.

Partnerships

Recorded partners

  • COPD Foundation
  • Optum Arcadia
  • Priority Health
  • Stanford Health Care
  • Y Combinator

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Kivo Health Virtual Pulmonary Rehabilitation Program

AI-powered virtual pulmonary rehab and care program for COPD patients

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

24% improvement in symptoms

COPD patients completing 9-week program

34% improvement in physical activity (functional capacity)

COPD patients completing program

25% improvement in mood

COPD patients completing program

83% program completion rate

Industry-leading adherence

3.1x ROI for health plans

Medicare Advantage plans

$8,245 PMPY cost savings

High-risk COPD members, primarily through reduced inpatient and SNF costs

$9.8M projected annual savings

Per 100,000 Medicare Advantage members

90 NPS

Patient satisfaction score

Optum Arcadia

AI-powered virtual lung rehab and care for patients in California

Priority Health

Partnership to provide virtual pulmonary rehabilitation for COPD patients

Stanford Health Care

Virtual COPD care and value-based care advancement through virtual pulmonary rehabilitation

Medicare Advantage Plans (General)

Reducing utilization costs for high-risk COPD members through virtual pulmonary rehabilitation

3.1x ROI, $8,245 PMPY in predicted cost savings, $9.8M projected annual savings per 100,000 MA members

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Shawn Dastmalchi

Advisor

06 · Company updates

Updates from Kivo Health

Recent articles published on Kivo Health's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Chronic Disease Management & Digital Therapeutics

Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon